Table 1 Patient and treatment... | American Society of Hematology

Table 1

Patient and treatment characteristics

Characteristic	n	%
Patients
Recruited	169
Intent to treat	168	100
Per protocol	162	96
Sex
Male	91	54
Female	77	46
Age, y
< 40	24	14
40-59	80	48
≥ 60	64	38
Diagnosis
Multiple myeloma	104	62
Hodgkin disease	14	8
Indolent lymphoma	17	10
Aggressive lymphoma	33	20
ECOG performance status
0	68	40
1	93	56
2	7	4
Previous cycles of chemotherapy
≤ 6	120	71
> 6	48	29
Previous radiotherapy
Yes	59	35
No	109	65
Remission status
Complete remission	22	13
Partial remission	97	58
Less than partial remission	49	29
High-dose regimens
MEL140	45	27
MEL200	59	35
BEAM	60	36
Others	4	2
CD34⁺ cells infused, ×10⁶/kg
2.0-5.0	106	63
> 5.0	62	37

Characteristic	n	%
Patients
Recruited	169
Intent to treat	168	100
Per protocol	162	96
Sex
Male	91	54
Female	77	46
Age, y
< 40	24	14
40-59	80	48
≥ 60	64	38
Diagnosis
Multiple myeloma	104	62
Hodgkin disease	14	8
Indolent lymphoma	17	10
Aggressive lymphoma	33	20
ECOG performance status
0	68	40
1	93	56
2	7	4
Previous cycles of chemotherapy
≤ 6	120	71
> 6	48	29
Previous radiotherapy
Yes	59	35
No	109	65
Remission status
Complete remission	22	13
Partial remission	97	58
Less than partial remission	49	29
High-dose regimens
MEL140	45	27
MEL200	59	35
BEAM	60	36
Others	4	2
CD34⁺ cells infused, ×10⁶/kg
2.0-5.0	106	63
> 5.0	62	37

ECOG indicates Eastern Cooperative Oncology Group.